DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor - Silva, Rangel Leal; Silveira, Gabriela Tosta; Wanderlei, Carlos W.; Cecilio, Nerry Tatiana; Maganin, Alexandre Gomes de Macedo; Franchin, Marcelo; Marques, Lucas Maciel Mauriz; Lopes, Norberto Peporine; Crippa, José Alexandre de Souza; Guimarães, Francisco Silveira; Alves-Filho, José Carlos Farias; Cunha, Fernando de Queiroz; et al. (Toxicology and Applied Pharmacology, 2019)